# Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects

> **NCT00418756** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT00418756
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-11
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2010-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418756, "Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00418756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*